Indivior PLC
INDV30.260USD
+1.470+5.11%
Handelsschluss 03/25, 16:00（ET）Kurse um 15 Minuten verzögert
3.78BMarktkapitalisierung
30.76KGV TTM
mehr Informationen über Indivior PLC Unternehmen
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Indivior PLC Informationen
BörsenkürzelINDV
Name des UnternehmensIndivior PLC
IPO-datumDec 24, 2014
CEOCiaffoni (Joseph J)
Anzahl der mitarbeiter1030
WertpapierartOrdinary Share
GeschäftsjahresendeDec 24
Addresse234 Bath Road
StadtSLOUGH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited Kingdom
PostleitzahlSL1 4EE
Telefon448043791090
Websitehttps://www.indivior.com/en
BörsenkürzelINDV
IPO-datumDec 24, 2014
CEOCiaffoni (Joseph J)
Führungskräfte von Indivior PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
246.51K
+22.61%
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
135.98K
+58.82%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
71.52K
+61.33%
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
19.50K
+23.07%
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
7.57K
-27.11%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
6.88K
+43.59%
Ms. Kathryn Barbara Hudson
Ms. Kathryn Barbara Hudson
Company Secretary
Company Secretary
--
--
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
246.51K
+22.61%
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
135.98K
+58.82%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
71.52K
+61.33%
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
19.50K
+23.07%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
267.00M
85.03%
Rest of World
47.00M
14.97%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Thu, Feb 19
Aktualisiert: Thu, Feb 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.45%
Oaktree Capital Management, L.P.
5.68%
Fuller & Thaler Asset Management Inc.
5.09%
Madison Avenue Partners LP
5.02%
The Vanguard Group, Inc.
4.36%
Andere
66.39%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.45%
Oaktree Capital Management, L.P.
5.68%
Fuller & Thaler Asset Management Inc.
5.09%
Madison Avenue Partners LP
5.02%
The Vanguard Group, Inc.
4.36%
Andere
66.39%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
26.76%
Investment Advisor/Hedge Fund
25.26%
Hedge Fund
23.81%
Research Firm
7.36%
Individual Investor
3.99%
Pension Fund
2.98%
Bank and Trust
0.42%
Family Office
0.15%
Andere
9.28%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1
2.06K
0.00%
--
2025Q3
372
118.02M
94.53%
+2.51M
2025Q2
354
123.13M
98.21%
+4.02M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
7.79M
6.24%
+2.75M
+54.61%
Sep 30, 2025
Oaktree Capital Management, L.P.
7.11M
5.69%
-1.64M
-18.71%
Dec 24, 2025
Fuller & Thaler Asset Management Inc.
3.17M
2.54%
+3.17M
--
Sep 30, 2025
Madison Avenue Partners LP
6.46M
5.18%
-1.46M
-18.41%
Sep 30, 2025
The Vanguard Group, Inc.
3.44M
2.76%
-2.18M
-38.82%
Sep 30, 2025
Two Seas Capital LP
6.21M
4.98%
-3.04M
-32.87%
Dec 23, 2025
Millennium Management LLC
2.46M
1.97%
+151.15K
+6.54%
Dec 15, 2025
Morgan Stanley & Co. LLC
5.58M
4.47%
+5.04M
+934.24%
Sep 30, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
Deerfield Management Company, L.P.
4.61M
3.7%
-2.37M
-33.95%
Nov 10, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Lattice Hartford Multifactor Small Cap ETF
1.11%
ProShares Ultra Nasdaq Biotechnology
0.51%
Federated Hermes MDT Small Cap Core ETF
0.47%
Janus Henderson Small Cap Growth Alpha ETF
0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
Invesco Nasdaq Biotechnology ETF
0.36%
Franklin US Small Cap Multifactor Index ETF
0.32%
First Trust Active Factor Small Cap ETF
0.31%
Vanguard US Multifactor ETF
0.27%
Pacer US Small Cap Cash Cows ETF
0.26%
Mehr Anzeigen
Lattice Hartford Multifactor Small Cap ETF
Anteil1.11%
ProShares Ultra Nasdaq Biotechnology
Anteil0.51%
Federated Hermes MDT Small Cap Core ETF
Anteil0.47%
Janus Henderson Small Cap Growth Alpha ETF
Anteil0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.38%
Invesco Nasdaq Biotechnology ETF
Anteil0.36%
Franklin US Small Cap Multifactor Index ETF
Anteil0.32%
First Trust Active Factor Small Cap ETF
Anteil0.31%
Vanguard US Multifactor ETF
Anteil0.27%
Pacer US Small Cap Cash Cows ETF
Anteil0.26%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
